Summary Keywords metabolite, biomarker, major depressive disorder, acetylcarnitine, remission status, drug treatment Citation Lee S, Mun S, Lee Y-R, Choi H, Joo E-J, Kang H-G and Lee J (2022) Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
It introduces confounding variables that make drawing any real conclusion impossible
Interestingly, antimicrobial assays revealed that Schisandra chinensis leaf extracts were even more effective than fruit extracts against targeted bacteria, underscoring the importance of plant part selection in maximizing antibacterial efficacy [9]
Side Effects of GLP-1 Patches Since patches havent been widely tested, the only clues we have about possible risks come from the supplement ingredients they contain: Possible side effects L-carnitine: nausea, diarrhea, fishy odor [24] Glutamine: bloating [12] Berberine: stomach upset, nausea, constipation [25] Pomegranate: digestive issues [26] Resveratrol: digestive issues, headaches [27] B-vitamins: flushing, nerve irritation at high doses [28] Chromium: mood changes, insomnia, headaches [29] More serious risks L-carnitine: may raise TMAO levels linked to heart disease [30] High-dose glutamine: may worsen seizures [31] Berberine: interacts with many prescription drugs
(2025, June)
The same degree of telogen effluvium that would be unnoticeable in a 30-year-old can be visually significant in a 65-year-old who already has thinner baseline hair